| Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers (NCT03624790) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-31 |
| Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management (NCT03591146) | Taiwan Liposome Company | 2018-07-31 |
| TIL and Anti-PD1 in Metastatic Melanoma (NCT03638375) | Leiden University | 2018-07-31 |
| CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer (NCT03517176) | Lisata Therapeutics, Inc. | 2018-07-31 |
| Safety and Pharmacokinetics Study of DM1157 to Treat Malaria (NCT03490162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-31 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female Participants (NCT03607513) | Janssen Research & Development, LLC | 2018-07-31 |
| Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001) (NCT03590392) | University of Oxford | 2018-07-31 |
| A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity (NCT03629041) | Innoture Ltd | 2018-07-31 |
| A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants (NCT03593954) | Janssen Research & Development, LLC | 2018-07-31 |
| Study Evaluating AMG 424 in Subjects With Multiple Myeloma (NCT03445663) | Xencor, Inc. | 2018-07-31 |
| A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234 (NCT05567367) | Respira Therapeutics, Inc. | 2018-07-31 |
| Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects (NCT03905291) | Medy-Tox | 2018-07-31 |
| Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies (NCT03151057) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-07-31 |
| ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE) (NCT03646240) | Seattle Children's Hospital | 2018-07-31 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a) (NCT03626662) | Amgen | 2018-07-30 |
| Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects (NCT03599063) | Pfizer | 2018-07-30 |
| Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea (NCT03590340) | Sanaria Inc. | 2018-07-30 |
| Tolerance by Engaging Antigen During Cellular Homeostasis (NCT03504241) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-30 |
| A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers (NCT04555850) | Beijing Northland Biotech. Co., Ltd. | 2018-07-30 |
| A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC (NCT03601598) | Harbin Medical University | 2018-07-30 |
| Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction (NCT03348293) | Xijing Hospital | 2018-07-30 |
| Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media (NCT03675841) | Lee's Pharmaceutical Limited | 2018-07-29 |
| Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions (NCT03616301) | Pharmtechnology LLC | 2018-07-28 |
| Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers (NCT03300570) | National Cancer Institute (NCI) | 2018-07-27 |
| A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults (NCT05109390) | Alexion Pharmaceuticals, Inc. | 2018-07-27 |
| Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer (NCT03480256) | Peking University | 2018-07-27 |
| A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects (NCT03593278) | Viatris Innovation GmbH | 2018-07-27 |
| Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS (NCT03502668) | Taiho Oncology, Inc. | 2018-07-27 |
| Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers (NCT03596632) | Hoffmann-La Roche | 2018-07-27 |
| A Study to Test Different Doses of BI 456906 in Patients With Obesity (NCT03591718) | Boehringer Ingelheim | 2018-07-26 |
| CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma (NCT03672253) | Second Affiliated Hospital of Xi'an Jiaotong University | 2018-07-26 |
| A Study of the Cardiac Effects of Danicopan in Healthy Adults (NCT05016206) | Alexion Pharmaceuticals, Inc. | 2018-07-26 |
| LCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma (NCT03674463) | Second Affiliated Hospital of Xi'an Jiaotong University | 2018-07-26 |
| Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment (NCT03557658) | Theracos | 2018-07-26 |
| HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (NCT03500991) | Seattle Children's Hospital | 2018-07-26 |
| A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants. (NCT03436316) | AstraZeneca | 2018-07-26 |
| Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers (NCT03568058) | Aaron Miller | 2018-07-26 |
| A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects (NCT03605082) | UCB Biopharma S.P.R.L. | 2018-07-25 |
| Study of ANX007 in Participants With Primary Open-angle Glaucoma (NCT04188015) | Annexon, Inc. | 2018-07-25 |
| SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer (NCT03596658) | Jiangsu HengRui Medicine Co., Ltd. | 2018-07-25 |
| A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese (NCT03600480) | Novo Nordisk A/S | 2018-07-25 |
| Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 (NCT03616392) | Chong Kun Dang Pharmaceutical | 2018-07-25 |
| Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors (NCT03517956) | Bayer | 2018-07-25 |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma (NCT03336606) | Providence Health & Services | 2018-07-25 |
| Study of the Safety of USB005 in Healthy Volunteers (NCT03615196) | US Biotest, Inc. | 2018-07-25 |
| Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease (NCT03611569) | H. Lundbeck A/S | 2018-07-25 |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma (NCT03328104) | Emory University | 2018-07-24 |
| Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome (NCT03617224) | University of Texas Southwestern Medical Center | 2018-07-24 |
| A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers (NCT03586726) | Hoffmann-La Roche | 2018-07-24 |
| Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines (NCT03481816) | National Cancer Institute (NCI) | 2018-07-24 |
| A Study of NPT189 in Healthy Subjects (NCT03610035) | Proclara Biosciences, Inc. | 2018-07-24 |
| ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML (NCT03595917) | Marlise Luskin, MD | 2018-07-24 |
| A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies (NCT03629756) | Arcus Biosciences, Inc. | 2018-07-24 |
| Study of HPN424 in Patients With Advanced Prostate Cancer (NCT03577028) | Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-07-24 |
| A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis (NCT03971825) | Celgene | 2018-07-24 |
| Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia (NCT03573700) | St. Jude Children's Research Hospital | 2018-07-24 |
| Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder (NCT03729128) | Tzu-Yun Wang | 2018-07-24 |
| Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response (NCT03694119) | Celgene | 2018-07-24 |
| Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma (NCT03604328) | PolyActiva Pty Ltd | 2018-07-24 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis (NCT03620474) | Kiminori Kimura, MD | 2018-07-24 |
| A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure (NCT03765346) | Grünenthal GmbH | 2018-07-24 |
| Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients (NCT03406897) | Rodolfo Alejandro | 2018-07-23 |
| A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML (NCT03690154) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2018-07-23 |
| Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children (NCT03447782) | Boston Children's Hospital | 2018-07-23 |
| A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools (NCT03598621) | Novo Nordisk A/S | 2018-07-23 |
| Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution (NCT04678076) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2018-07-23 |
| Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (NCT03613129) | LUCINDA BATEMAN, MD | 2018-07-23 |
| A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03484520) | AbbVie | 2018-07-23 |
| Pediatric MSC-AFP Sub-study for Crohn's Fistula (NCT03449069) | Mayo Clinic | 2018-07-23 |
| Side Effects of Atropine (SEA) Study (NCT03593044) | Jeffrey J. Walline, OD PhD | 2018-07-23 |
| Study to Evaluate CCS1477 in Advanced Tumours (NCT03568656) | CellCentric Ltd. | 2018-07-23 |
| Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study (NCT03652623) | Hektoen Institute for Medical Research | 2018-07-23 |
| Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T) (NCT03585517) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2018-07-21 |
| CD19-CAR-T Cells in Patients With R/R B-ALL (NCT03574168) | Bioceltech Therapeutics, Ltd. | 2018-07-20 |
| First-line Combination Treatment Based on Anlotinib (NCT03628521) | Shanghai Chest Hospital | 2018-07-20 |
| Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy (NCT03171493) | Vyriad, Inc. | 2018-07-20 |
| HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma (NCT03354390) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-07-20 |
| Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide (NCT03801759) | Akebia Therapeutics | 2018-07-20 |
| Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin (NCT03801746) | Akebia Therapeutics | 2018-07-20 |
| A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty (NCT03497039) | GlaxoSmithKline | 2018-07-19 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery (NCT03582124) | Stanford University | 2018-07-19 |
| A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan (NCT03596294) | Idorsia Pharmaceuticals Ltd. | 2018-07-19 |
| Phase I Study of GSK2982772 in Japanese Healthy Male Participants (NCT03590613) | GlaxoSmithKline | 2018-07-19 |
| Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies (NCT03987685) | Athenex, Inc. | 2018-07-19 |
| Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers (NCT03610945) | Enanta Pharmaceuticals, Inc | 2018-07-19 |
| PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers (NCT03488186) | First Affiliated Hospital of Zhejiang University | 2018-07-19 |
| Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects (NCT06323655) | Vanda Pharmaceuticals | 2018-07-19 |
| A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies (NCT03560882) | Joaquina Baranda | 2018-07-19 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers (NCT03452332) | M.D. Anderson Cancer Center | 2018-07-18 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers (NCT03609294) | Boryung Pharmaceutical Co., Ltd | 2018-07-18 |
| Antibiotics, Gastric Bypass, and the Microbiome (NCT05367479) | Medical College of Wisconsin | 2018-07-18 |
| The Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer Subjects (NCT03582280) | Amorphical Ltd. | 2018-07-18 |
| Assessment of the Human Systemic Absorption of Sunscreen Ingredients (NCT03582215) | Food and Drug Administration (FDA) | 2018-07-18 |
| A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. (NCT03549000) | Novartis Pharmaceuticals | 2018-07-18 |
| Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL (NCT03471351) | Rhizen Pharmaceuticals SA | 2018-07-18 |
| Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors (NCT03525925) | Ohio State University Comprehensive Cancer Center | 2018-07-18 |
| Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL (NCT03524235) | Noah Merin | 2018-07-18 |
| Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer (NCT03751592) | Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd | 2018-07-17 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (NCT03776994) | SRI International | 2018-07-17 |
| Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma (NCT03817567) | Sinocelltech Ltd. | 2018-07-17 |